UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 259

Sortiert nach

Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis

Annals of internal medicine, 2001-08, Vol.135 (4), p.248

2001

Volltextzugriff (PDF)

Measuring quality in arthritis care: Methods for developing the Arthritis Foundation's quality indicator set

Arthritis and rheumatism, 2004-04, Vol.51 (2), p.193-202

2004

Volltextzugriff (PDF)

Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset

Arthritis research, 2000-01, Vol.2 (3), p.236-243, Article 236

2000

Volltextzugriff (PDF)

Primer on the Rheumatic Diseases

13th ed., 2008

Volltextzugriff (PDF)

Biologic Therapy for Rheumatoid Arthritis

The New England journal of medicine, 2000-11, Vol.343 (22), p.1640-1641

Klippel, John H

2000

Volltextzugriff (PDF)

End-stage renal disease and systemic lupus erythematosus

The American journal of medicine, 1996-07, Vol.101 (1), p.100-107

1996

Volltextzugriff (PDF)

Second-Line Drug Therapy for Rheumatoid Arthritis

The New England journal of medicine, 1994-05, Vol.330 (19), p.1368-1375

1994

Volltextzugriff (PDF)

Systemic Lupus Erythematosus: Presence in Human Serum of an Unusual Acid-Labile Leukocyte Interferon

Science (American Association for the Advancement of Science), 1982-04, Vol.216 (4544), p.429-431

1982

Volltextzugriff (PDF)

Effect of treatment on the evolution of renal abnormalities in lupus nephritis

The New England journal of medicine, 1984-08, Vol.311 (8), p.491

1984

Volltextzugriff (PDF)

Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial

Annals of internal medicine, 1996-10, Vol.125 (7), p.549

1996

Volltextzugriff (PDF)

Systemic lupus erythematosus. Treatment-related complications superimposed on chronic disease

JAMA : the journal of the American Medical Association, 1990-04, Vol.263 (13), p.1812

Klippel, J H

1990

Volltextzugriff (PDF)

Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy

Annals of internal medicine, 1993-09, Vol.119 (5), p.366

1993

Volltextzugriff (PDF)

Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease

Annals of internal medicine, 1995-06, Vol.122 (12), p.940

1995

Volltextzugriff (PDF)

Systemic lupus erythematosus: demographics, prognosis, and outcome

Journal of rheumatology. Supplement, 1997-05, Vol.48, p.67

Klippel, J H

1997

Volltextzugriff (PDF)

Predicting Who Will Get Lupus Nephritis

Journal of clinical rheumatology, 1995-10, Vol.1 (5), p.257-259

Klippel, John H

1995

Volltextzugriff (PDF)

Modified oral ondansetron regimen for cyclophosphamide-induced emesis in lupus nephritis

The Annals of pharmacotherapy, 1996-07, Vol.30 (7-8), p.752

1996

Volltextzugriff (PDF)

Systemic lupus erythematosus: emerging concepts. Part 2: Dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis

Annals of internal medicine, 1995-07, Vol.123 (1), p.42

1995

Volltextzugriff (PDF)

Editorial: Biologic therapy for rheumatoid arthritis

The New England journal of medicine, 2000-11, Vol.343 (22), p.1640

Klippel, John H

2000

Volltextzugriff (PDF)

Use of cytotoxic agents and cyclosporine in the treatment of autoimmune disease. Part 2: Inflammatory bowel disease, systemic vasculitis, and therapeutic toxicity

Annals of internal medicine, 1998-07, Vol.129 (1), p.49

1998

Volltextzugriff (PDF)

Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: consensus on a preliminary core set of outcome domains

Journal of rheumatology, 1999-02, Vol.26 (2), p.504

1999

Volltextzugriff (PDF)

UPDATE ON CYCLOPHOSPHAMIDE FOR SYSTEMIC LUPUS ERYTHEMATOSUS

Rheumatic diseases clinics of North America, 2000-05, Vol.26 (2), p.363-375

2000

Volltextzugriff (PDF)

Is Malignancy a Major Concern in Rheumatoid Arthritis Patients?

Journal of clinical rheumatology, 1995-02, Vol.1 (1), p.14-22

1995

Volltextzugriff (PDF)

Methotrexate in rheumatoid arthritis

The New England journal of medicine, 1985-03, Vol.312 (13), p.853

1985

Volltextzugriff (PDF)

B-lymphocyte alloantigens associated with systemic lupus erythematosus

The New England journal of medicine, 1978-09, Vol.299 (10), p.515

1978

Volltextzugriff (PDF)

8 Indications for, and use of, cytotoxic agents in SLE

Baillière's clinical rheumatology, 1998-08, Vol.12 (3), p.511-527

Klippel, John H.

1998

Volltextzugriff (PDF)

1 – 25 von 259

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(220)

Publikationsform

Sprache

Englisch
(259)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Rheumatology
(122)
Dermatology
(92)
Orthopaedics & Fractures
(90)
Humans
(77)
Science & Technology
(67)
Life Sciences & Biomedicine
(65)
Female
(46)
Adult
(40)
Male
(37)
Biological And Medical Sciences
(32)
Medical Sciences
(32)
Middle Aged
(32)
General & Internal Medicine
(24)
Medicine, General & Internal
(23)
Lupus Erythematosus, Systemic - Complications
(16)
Rheumatoid Arthritis
(14)
Carpal Tunnel Syndrome
(13)
Cyclophosphamide - Adverse Effects
(12)
Pharmacology. Drug Treatments
(12)
Cyclophosphamide - Therapeutic Use
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis

Measuring quality in arthritis care: Methods for developing the Arthritis Foundation's quality indicator set

Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset

Primer on the Rheumatic Diseases

Biologic Therapy for Rheumatoid Arthritis

End-stage renal disease and systemic lupus erythematosus

Second-Line Drug Therapy for Rheumatoid Arthritis

Systemic Lupus Erythematosus: Presence in Human Serum of an Unusual Acid-Labile Leukocyte Interferon

Effect of treatment on the evolution of renal abnormalities in lupus nephritis

Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial

Systemic lupus erythematosus. Treatment-related complications superimposed on chronic disease

Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy

Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease

Systemic lupus erythematosus: demographics, prognosis, and outcome

Predicting Who Will Get Lupus Nephritis

Modified oral ondansetron regimen for cyclophosphamide-induced emesis in lupus nephritis

Systemic lupus erythematosus: emerging concepts. Part 2: Dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis

Editorial: Biologic therapy for rheumatoid arthritis

Use of cytotoxic agents and cyclosporine in the treatment of autoimmune disease. Part 2: Inflammatory bowel disease, systemic vasculitis, and therapeutic toxicity

Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: consensus on a preliminary core set of outcome domains

UPDATE ON CYCLOPHOSPHAMIDE FOR SYSTEMIC LUPUS ERYTHEMATOSUS

Is Malignancy a Major Concern in Rheumatoid Arthritis Patients?

Methotrexate in rheumatoid arthritis

B-lymphocyte alloantigens associated with systemic lupus erythematosus

8 Indications for, and use of, cytotoxic agents in SLE

Suchergebnisse filtern